Loading...
Chemical structure of Neuromuscular Disorder-Targeting Compound 1

GC31288

Neuromuscular Disorder-Targeting Compound 1

Also known as (4aR,8aR)-7-(methylsulfanylmethyl)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[5,4-g]quinoline

Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome

ChemicalCAS374538-23-5MW279.44FormulaC15H25N3S
CAS number
374538-23-5
Molecular weight
279.44
Formula
C15H25N3S
Solubility
Soluble in DMSO
InChIKey
ASXNINCAPWBRJS-AADWAWOOSA-N
Catalogue number
GC31288
Brand
GLPBIO
Computed properties PubChem CID 6917765 · XLogP 2.8 · TPSA 57.2 Ų · H-bond donors 1
XLogP
2.8
TPSA
57.2 Ų
H-bond donors
1
H-bond acceptors
3
Rotatable bonds
4
Heavy atoms
19

SMILES CCCN1CC(C[C@H]2[C@H]1CC3=C(C2)NN=C3)CSC

Computed descriptors from PubChem (CID 6917765), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.